Skip to main content
. 2013 Jul 24;7:627–633. doi: 10.2147/DDDT.S47156

Table 2.

Citrate hemofiltration was started to reduce the risk of systemic anticoagulation

Day 1 2 3 4 5 6 7 8
Plasmaseparation Citrate Citrate Citrate Citrate Citrate Citrate Citrate Citrate
Hemofiltration Citrate Citrate Heparin Heparin Argatroban Argatroban Argatroban
Decrease of hemoptysis Thrombocytopenia

Notes: Decreasing hemoptysis enabled a change to heparin on day 4. Because of developing thrombocytopenia hemofiltration was continued on argatroban. Plasmapheresis was administered with citrate as standard in our department. ↑, increased; →, ongoing treatment.